Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma or Gliosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00402116
What this trial is testing

Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma
Eli Lilly and Company 72
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Testing effectiveness (Phase 2)UnknownNCT00054496
What this trial is testing

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
The Cleveland Clinic 73
Early research (Phase 1)Study completedNCT00069940
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT01836549
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more
Pediatric Brain Tumor Consortium 43
Early research (Phase 1)Study completedNCT00526812
What this trial is testing

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Who this might be right for
Glioma
Biogen 54
Early research (Phase 1)Ended earlyNCT02031965
What this trial is testing

Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery

Who this might be right for
Recurrent Childhood Anaplastic AstrocytomaRecurrent Childhood Anaplastic OligoastrocytomaRecurrent Childhood Anaplastic Oligodendroglioma+4 more
Pediatric Brain Tumor Consortium 2
Testing effectiveness (Phase 2)Ended earlyNCT01822275
What this trial is testing

Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme

Who this might be right for
Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
University of Maryland, Baltimore 24
Not applicableStudy completedNCT00967200
What this trial is testing

Study of Tissue Samples From Patients With Glioma or Other Brain Tumors

Who this might be right for
Central Nervous System Lymphoma
University Hospital, Montpellier 180
Early research (Phase 1)Study completedNCT02457845
What this trial is testing

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Who this might be right for
Supratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more
Gregory K. Friedman, MD 13
Testing effectiveness (Phase 2)Study completedNCT03150862
What this trial is testing

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
BeiGene USA, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT00128700
What this trial is testing

Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 20
Testing effectiveness (Phase 2)Study completedNCT00085566
What this trial is testing

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Who this might be right for
Brain and Central Nervous System TumorsProstate Cancer
Memorial Sloan Kettering Cancer Center 61
Early research (Phase 1)Study completedNCT00049387
What this trial is testing

Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT00017147
What this trial is testing

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
SWOG Cancer Research Network 183
Testing effectiveness (Phase 2)Study completedNCT01609790
What this trial is testing

Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma+3 more
National Cancer Institute (NCI) 137
Early research (Phase 1)Study completedNCT00005813
What this trial is testing

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Active Not RecruitingNCT02062827
What this trial is testing

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Who this might be right for
Recurrent Glioblastoma MultiformeProgressive Glioblastoma MultiformeAnaplastic Astrocytoma or Gliosarcoma
University of Alabama at Birmingham 29
Next Page